rethinkTHC Search
Menu
Study breakdown

THC Slowed Thinking More in Lighter Cannabis Users Than Heavier Ones

Randomized Controlled TrialPreliminary evidence
The takeaway

In a placebo-controlled experiment with 30 young cannabis users, THC did not impair cognitive efficiency on average, but individuals with less recent cannabis use showed greater cognitive slowing.

Cannabis consumers interested in tolerance effects, researchers studying cannabis impairment, policymakers working on impairment standards

Less recent cannabis use predicted greater cognitive slowing from THC

What the researchers found

Overall, 7.5mg oral THC did not significantly alter cognitive performance compared to placebo. However, there was high variability between individuals. Those with less recent cannabis use experienced greater cognitive slowing (slower drift rates), and those who reported stronger subjective drug effects also showed poorer cognitive efficiency.

Why it matters

This study helps explain why THC impairment research produces mixed results: the effects vary dramatically between individuals based on their tolerance level. Computational modeling reveals heterogeneity that traditional analyses may miss.

The numbers in context

N=30, ages 18-25, 53% men. Dose: 7.5mg oral THC vs placebo. No significant overall group effects on drift rate, boundary separation, or non-decision time. Less recent cannabis use predicted greater cognitive slowing. Stronger subjective "high" and "effect" ratings correlated with poorer cognitive efficiency.

How the study worked

Double-blind, placebo-controlled THC administration experiment with 30 occasional to regular cannabis users aged 18-25. Participants completed a Go/No-Go task at peak drug effect under both conditions. Data were analyzed using drift diffusion modeling and Bayesian statistics.

What this study cannot tell us

Small sample (N=30) of young, experienced cannabis users. Single dose level (7.5mg) limits generalizability. Only one cognitive task (Go/No-Go). Cannot determine whether tolerance-related differences reflect neuroadaptation or behavioral compensation.

How to read the evidence

Preliminary evidence from a small but well-designed placebo-controlled experiment with computational modeling.

When this study was published

2025 study using advanced computational methods to examine THC effects on cognition.

The bigger picture

The concept of cannabis tolerance is well-known anecdotally, but this study provides computational evidence that tolerance genuinely reduces acute cognitive impairment from THC. This has implications for impairment testing, workplace policies, and understanding individual risk.

Questions still open

  • At what point does tolerance develop enough to meaningfully reduce cognitive impairment? Do these findings extend to higher THC doses? How should individual differences in tolerance be accounted for in impairment testing?

Common questions

Did THC impair thinking in this study?
On average, no. But the effects varied widely between individuals. People who used cannabis less recently showed more cognitive slowing after THC, while more frequent users showed less impairment, consistent with tolerance.
How was tolerance measured?
Researchers used recent cannabis use frequency and subjective drug effects (how "high" participants felt) as indicators. Those with less recent use and stronger subjective effects showed greater cognitive impairment.

Read the original research

Acute effects of Δ9-tetrahydrocannabinol on computational measures of neurocognitive processes are related to recent cannabis use among adolescents and young adults.

Frontiers in adolescent medicine, 3

Citation

Paige, K J; Weigard, A S; Ajilore, O; Phan, K L; de Wit, H; Klumpp, H; Crane, N A. (2025). Acute effects of Δ9-tetrahydrocannabinol on computational measures of neurocognitive processes are related to recent cannabis use among adolescents and young adults.. Frontiers in adolescent medicine, 3. https://doi.org/10.3389/fradm.2025.1541068

Explore the wider topic